Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | GALR3 | O60755 | 2/20 | 0.45 |
| ▸ | NR2F2 | P24468 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | APP | P05067 | 3/20 | 0.42 |
| ▸ | PDE2A | O00408 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.33 |
| ▸ | HTR3A | P46098 | 1/20 | 0.33 |
| ▸ | USP28 | Q96RU2 | 3/20 | 0.33 |
| ▸ | USP25 | Q9UHP3 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5427198 | 0.82 | APP (0.60) | NPC1GALR3NR2F2RAB9AAPP | |
| SCHEMBL7014005 | 0.82 | BCDIN3D (0.46) | NPC1GALR3NR2F2RAB9AAPP | |
| SCHEMBL31044730 | 0.76 | NPC1 (0.39) | NPC1GALR3NR2F2RAB9AAPP | |
| SCHEMBL31045039 | 0.76 | APP (0.51) | APPCYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL31045122 | 0.76 | NPC1 (0.39) | NPC1GALR3NR2F2RAB9AAPP | |
| SCHEMBL5436049 | 0.75 | NPC1 (0.47) | NPC1GALR3NR2F2RAB9ACYP1A2 | |
| SCHEMBL31045140 | 0.73 | NPC1 (0.45) | NPC1GALR3NR2F2RAB9AAPP | |
| SCHEMBL5123729 | 0.73 | ESR1 (0.46) | APPPDE2AESR1HRH4ALDH1A1 | |
| SCHEMBL5123979 | 0.73 | ESR1 (0.43) | APPPDE2AESR1 | |
| SCHEMBL31045066 | 0.73 | NPC1 (0.35) | NPC1GALR3NR2F2RAB9AAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080045529-A1 | Use Of Thienopyrimidines | MERCK PATENT GMBH (DE) | 2008-02-21 | — | — | US | disclosed |
| US-6110920-A | TREATMENT OF CARDIOVASCULAR DISORDERS AND IMPOTENCY | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2000-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080045529-A1 | Use Of Thienopyrimidines | TIE1, DPYD, TK2 | NPC1 4863/4885GALR3 3917/4885NR2F2 1124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.